Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
10/2011
10/26/2011CN102227421A Anti-proliferation compounds
10/26/2011CN102227420A Quinazolinone, quinolone and related analogs as sirtuin modulators
10/26/2011CN102227412A Fungicide hydroximoyl-heterocycles derivatives
10/26/2011CN102227409A Pyridine-3-carboxyamide derivative
10/26/2011CN102225930A Method of treatment of age-related macular degeneration(AMD)
10/26/2011CN102225926A Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties
10/26/2011CN101817818B Compound used for preparing montelukast sodium
10/26/2011CN101070304B Quinoline derivatives and their use as mycrobacterial inhibitors
10/25/2011US8044230 Water-soluble prodrugs of chloramphenicol, thiamphenicol, and analogs thereof
10/25/2011US8044208 Imidazole derivatives as inhibitors of TAFIa
10/25/2011US8044080 having the cyclic carboxylic acid hemiketal moiety; treating inflammation or preventing apoptosis; dementia, cerebral stroke, brain impairment
10/25/2011US8044079 Substituted oxindole derivatives, medicaments containing said derivatives and use thereof
10/25/2011US8044054 Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses
10/25/2011US8044047 5-substituted benzoxazines
10/25/2011US8044041 Phthalazine derivatives as inhibitors of protein kinase
10/20/2011WO2011130500A1 Formulations of a pyridazine bipyrazinyl
10/20/2011WO2011130419A2 Broad spectrum antiviral and antiparasitic agents
10/20/2011WO2011130383A1 Compounds containing fused rings which inhibit beta-secretase activity and methods of use thereof
10/20/2011WO2011128388A2 Oxazole and thiazole compounds as ksp inhibitors
10/20/2011WO2011128279A1 Arylethynyl derivatives
10/20/2011WO2011128251A1 Novel 3,3-dimethyl tetrahydroquinoline derivatives
10/20/2011WO2011127794A1 Chiral cyclic beta-amino aryl butyric acid derivatives, their preparation methods and methods for preparation of chiral beta-amino aryl butyric acid derivatives via them
10/20/2011WO2011101304A3 Piperidine derivatives
10/20/2011WO2011092293A3 Cyclohexyl amide derivatives as crf receptor antagonists
10/20/2011WO2011082268A3 Substituted naphthalenyl-pyrimidine compounds
10/20/2011WO2011066482A3 Chiral synthesis of isoxazolines, isoxazoline compounds, and uses thereof
10/20/2011WO2011047390A3 Heterocyclic benzoxazole compositions as inhibitors of hepatitis c virus
10/20/2011US20110257392 Intermediate compound for synthesizing pharmaceutical agent and production method thereof
10/20/2011US20110257391 Process for production of quinazoline derivative
10/20/2011US20110257389 Cross-linked cyclic amine compounds and agents for pest control
10/20/2011US20110257221 Novel hydroxy-6-heteroarylphenanthridines and their use as pde4 inhibitors
10/20/2011US20110257183 Bis-aryl sulfonamides
10/20/2011US20110257182 Novel amido derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
10/20/2011US20110257181 Pyridazinone derivatives
10/20/2011US20110257180 Novel Polymorphic Forms of 6-(1-methyl-1H-pyrazol-4-yl)-2--2H-pyridazin-3-one Dihydrogenphosphate and Processes of Manufacturing thereof
10/20/2011US20110257179 Novel thiazoles derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
10/20/2011US20110257178 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
10/20/2011US20110257177 Benzylthiotetrazole inhibitors of store operated calcium release
10/20/2011US20110257171 Novel imidazo[1,2-a]pyridine derivatives, method for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use in particular as met inhibitors
10/20/2011US20110257169 Novel hydroxy-6-heteroarylphenanthridines and their use as pde4 inhibitors
10/20/2011US20110257164 Dipeptidyl peptidase iv inhibitors
10/20/2011US20110257156 Gamma secretase modulators
10/20/2011US20110257154 Compounds and compositions as protein kinase inhibitors
10/20/2011US20110257151 Novel 3,3-dimethyl tetrahydroquinoline derivatives
10/20/2011US20110257014 1-(Heteroaryl)pyrazol-4-ylacetic acids, processes for their preparation and their use as herbicides and plant growth regulators
10/20/2011US20110257011 Substituted Amidine Compounds for Combating Animal Pests
10/20/2011US20110256175 Amino lipids and methods for the delivery of nucleic acids
10/20/2011US20110256128 Triazole compounds as ksp inhibitors
10/20/2011US20110256064 Novel Compounds for the Treatment of Diseases Associated with Amyloid or Amyloid-like Proteins
10/20/2011US20110253994 Compound for organic optoelectronic device, organic light emitting diode including the same and display device including the same
10/20/2011CA2795387A1 Novel 3,3-dimethyl tetrahydroquinoline derivatives
10/20/2011CA2786216A1 Arylethynyl derivatives
10/19/2011EP2377864A1 Piperidine GPCR agonists
10/19/2011EP2377863A1 Piperidine GPCR agonists
10/19/2011EP2377860A1 Novel compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
10/19/2011EP2377854A1 N-phenyl-dioxo-hydropyrimidines useful as hepatitis C virus (HCV) inhibitors
10/19/2011EP2377539A1 Quinazoline analogs as receptor tyrosine kinase inhibitors
10/19/2011EP2376495A2 Compositions of protein receptor tyrosine kinase inhibitors
10/19/2011EP2376485A1 Pyrazine derivatives useful as inhibitors of atr kinase
10/19/2011EP2376484A1 Oxadiazole fused heterocyclic derivatives useful for the treatment of multiple sclerosis
10/19/2011EP2376479A1 Substituted furancarboxamides, and use thereof
10/19/2011EP2376478A2 Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease
10/19/2011EP2376475A1 4-azetidinyl-1-heteroaryl-cyclohexanol antagonists of ccr2
10/19/2011EP2376473A1 3,4 - substituted piperidine derivatives as renin inhibitors
10/19/2011EP2376464A1 Fungicide hydroximoyl-heterocycles derivatives
10/19/2011EP2376455A1 Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors
10/19/2011EP2376454A2 Inhibitors of diacylglycerol acyltransferase
10/19/2011EP2376083A1 Quinazoline inhibitors of bace 1 and methods of using
10/19/2011EP2375904A1 Biaryl carboxamides
10/19/2011EP2375899A1 Piperidine-containing compounds and use thereof
10/19/2011EP2004607B1 (4-(4-[6-(trifluoromethyl-pyridin-3-ylamino)-N-containing-heteroaryl]-phenyl)-cyclohexyl)-acetic acid derivatives and pharmaceutical uses thereof
10/19/2011EP1494671B1 1-(4-piperidinyl)benzimidazolones as histamine h3 antagonists
10/19/2011EP1482931B1 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
10/19/2011EP1041982B1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS
10/19/2011CN1251097B Phthalazines with angiogenesis inhibiting activity
10/19/2011CN102224151A Novel antimicrobials
10/19/2011CN102224142A Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity
10/19/2011CN102219785A Triazine-containing benzoxazine, triazine-containing benzoxazine polymer, and preparation method thereof
10/19/2011CN102219784A Heteroaryl urea derivatives useful for inhibiting CHKl
10/19/2011CN102219750A N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
10/19/2011CN101223165B Ethanolamine salt of N- (3-methoxy-5-methylpyrazin-2yl) -2- (4- [1 , 3 , 4-0xadiaz0le-2-yl] phenyl) pyridine-3- sulphonamide
10/19/2011CN101180296B Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide - derivatives as factor Xa inhibitors
10/18/2011US8039486 Viricides, immunomodulators or HIV entry inhibitors; lymphadenopathy associated virus, human T-cell leukemia/lymphoma virus; AIDS
10/18/2011US8039470 Kinase inhibitor compounds
10/18/2011US8039469 Phosphatidylinositol 3 (PI3); Mammalian Target of Rapamycin, mTOR; triazine compounds substituted with either morpholino or tetrahydropyranyl rings on the triazine ring; anticancer agents, atherosclerosis, bone disorders, psoriasis, BPH, pancreatitis, kidney disease
10/18/2011US8039467 Compounds for the treatment of inflammatory disorders
10/18/2011US8039458 HIV integrase inhibitors
10/18/2011CA2598294C Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate derivative
10/18/2011CA2579207C Morpholine compound
10/18/2011CA2475312C N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as ddp-iv inhibitors
10/18/2011CA2398018C Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
10/13/2011WO2011127051A1 Modulators of the gpr119 receptor and the treatment of disorders related thereto
10/13/2011WO2011125317A1 Triazole derivative and pest control agent
10/13/2011WO2011124087A1 Oxadiazole-based piperazine derivatives and applications thereof
10/13/2011WO2011123947A1 Synthesis of chiral 2-(1h-indazol-6-yl)-spiro[cyclopropane-1,3'- indolin]-2'-ones
10/13/2011WO2011123946A1 Kinase inhibitors and method of treating cancer with same
10/13/2011WO2011123937A1 Kinase inhibitors and method of treating cancer with same
10/13/2011WO2011091840A3 Materials for organic electroluminescent devices
10/13/2011WO2011067236A3 Raltegravir polymorphs
10/13/2011WO2011038086A3 Indolizine inhibitors of 5-lipoxygenase
1 ... 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 ... 647